Zhanshuo Xiao - Publications

Vitiligo secondary to immunosuppressants: a pharmacovigilance study of the FDA Adverse Event Reporting System.

Journal: Frontiers in immunology

Published: September 17, 2025

Hidradenitis suppurativa and psychiatric disease: the need for nuanced analysis.

Journal: The British journal of dermatology

Published: July 25, 2025

Drug-Associated Pemphigus Reported by Physicians: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System.

Journal: Journal of cutaneous medicine and surgery

Published: May 15, 2025

The Pendulum of Adherence: An Interpretative Phenomenological Analysis of Psoriasis Treatment Discontinuation.

Journal: Patient preference and adherence

Published: March 17, 2025

Melanosis Secondary to Drugs: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).

Journal: Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)

Published: March 07, 2025

Mining and analysis of adverse event signals of isotretinoin based on the real-world data of FAERS database.

Journal: Frontiers in medicine

Published: January 13, 2025

Regarding 'experiences of young adults affected by cancer within an 8-week yoga intervention delivered by videoconference: a qualitative interview study'.

Journal: Annals of medicine

Published: December 23, 2024

Melasma secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system (FAERS).

Journal: BMC pharmacology & toxicology

Published: December 03, 2024

Real world pharmacovigilance study of antineoplastic drug related vitiligo risks.

Journal: Scientific reports

Published: November 23, 2024

Drug-induced dermatomyositis: a pharmacovigilance study of the FDA adverse event reporting system.

Journal: Frontiers in pharmacology

Published: November 12, 2024

Linear IgA bullous dermatosis secondary to drugs: a real-world pharmacovigilance study of the FDA adverse event reporting system.

Journal: Frontiers in medicine

Published: November 02, 2024

Acrodermatitis Continua of Hallopeau and Generalised Pustular Psoriasis: Case Reports of Two Different Manifestations of IL36RN Mutation in Siblings.

Journal: Psoriasis (Auckland, N.Z.)

Published: October 18, 2024